Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Elisabeth

Elisabeth Abom, Linkoping SE

Patent application number	Description	Published
20100206529	A Brazing Piece, a Method of Making a Brazing Piece, and a Method of Brazing and Components Made From Said Brazing Piece - The invention relates to a self-fluxing brazing piece. The piece comprises a composite material comprising at least one inorganic material distributed in a metal or metal alloy matrix, the inorganic material forming a flux during brazing to promote the formation of a thermally induced metallic bond. The matrix may be an aluminium silicon brazing alloy and the inorganic material may be a potassium-fluoro-aluminate flux. The piece is made by spray forming.	08-19-2010

Elisabeth Adderson, Memphis, TN US

Patent application number	Description	Published
20100196379	Group B Streptococcus Polypeptides Nucleic Acids and Therapeutic Compositions and Vaccines Thereof - This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids encoding Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD and EmaE. The present invention provides isolated polypeptides comprising amino acid sequences of Group B streptococcal polypeptides EmaA, EmaB, EmaC, EmaD and EmaE, including analogs, variants, mutants, derivatives and fragments thereof. Ema homologous polypeptides from additional bacterial species, including	08-05-2010

Elisabeth Alfonsson, Avesta SE

Patent application number	Description	Published
20100172785	Ferritic-austenitic stainless steel - A ferritic-austenitic stainless steel having a microstructure which essentially consists of 35-65 vol-% ferrite and 35-65 vol-% austenite, has a chemical composition which contains in weight-%: 0.005-0.07 C, 0.1-2.0 Si, 3-8 Mn, 19-23 Cr, 0.5-1.7 Ni, optionally Mo and/or W in a total amount of max 1.0 (Mo+W/2), optionally Cu up to max 1.0 Cu, 0.15-0.30 N, balance iron and impurities. The following conditions shall apply for the chromium and nickel equivalents: 20	07-08-2010

Elisabeth Arkenau, Koln DE

Patent application number	Description	Published
20080317854	PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM - The present invention relates to a process for the production of an abuse-proofed solid dosage form containing at least one active ingredient with potential for abuse and a binder with a breaking strength of =500 N, by exposing a mixture comprising the active ingredient and the binder to ultrasound and force.	12-25-2008

Elisabeth Boissier, Vallda SE

Patent application number	Description	Published
20080300564	Absorbent Product - An absorbent product having a rear part, a front part and a crotch part in its longitudinal direction, including a liquid permeable perforated top sheet facing the wearer, a liquid impermeable back sheet facing away from the wearer, and an absorbent structure positioned between the top sheet and the back sheet, and whereby longitudinally extending textile-like edges are positioned on both longitudinal sides of the top sheet, whereby the rear part of the absorbent structure is rounded in the form of at least three different radii. Hereby, it is possible to adjust the shape of the absorbent structure so that more absorbent material is put in the product.	12-04-2008
20090247978	ABSORBENT PRODUCT - An absorbent product having an extent in a plane in the longitudinal direction and the lateral direction and a thickness perpendicular to the plane when the product is positioned in a plane position. The absorbent product includes a backing layer and a top layer, the absorbent product exhibiting in the longitudinal direction a rear section, a front section and positioned between them a central section, and exhibiting in the lateral direction a first lateral zone, a second lateral zone and positioned between them a central zone. The top layer includes slits as the only openings in an area which fully or partially encloses that part of the absorbent product that is formed by the section of the central zone and the central section, and which constitutes the wet area of the product. Lotion is placed directly under the top layer within the area containing slits.	10-01-2009
20090306614	TOP LAYER FOR AN ABSORBENT ARTICLE - An absorbent product such as a panty liner or a sanitary towel or the like having two lateral zones and situated between them a central zone, the absorbent product having a top layer consisting of a laminate of a first layer of material containing openings and a second layer of material. The first layer of material covers at least the two lateral zones, and in that the second layer of material covers both the two lateral zones and the central zone, the top layer being folded over itself in such a way that an overlap is formed with a Z-shaped cross section, the overlapping parts being joined together via an inner joining zone. A method for the manufacture of such an absorbent product.	12-10-2009
20100004615	ABSORBENT PRODUCT - An absorbent product having an extent in a plane in the longitudinal direction and the lateral direction when the product is positioned in a plane position and a thickness perpendicular to the plane. The absorbent product includes a backing layer and a top layer and between them an absorption body, the absorbent product being divided up in the longitudinal direction into a rear section, a front section and positioned between them a central section, and being divided up in the lateral direction into a first lateral zone, a second lateral zone and positioned between them a central zone. The top layer includes slits in an area which fully or partially encloses that part of the absorbent product that is formed by the section of the central zone and the central section, and which constitutes the wet area of the product.	01-07-2010
20100036355	Absorbent Article - An absorbent article, especially an incontinence pad, having a length and a width extension, the length being greater than the width, and including absorbent core material, wherein the absorbent core material forms a central portion (	02-11-2010
20110106036	ABSORBENT PRODUCT - The invention refers to an absorbent product including a liquid permeable apertured top sheet facing the wearer during use, and a liquid-impermeable back sheet facing away from the wearer during use, whereby longitudinally extending textile-like edges are positioned on both longitudinal sides of the top sheet whereby the textile-like edges comprise apertures. Hereby, the textile-like edges will amongst others have the capacity to transport moisture that is formed at the interface between the textile-like edges and the wearer skin. Further, the apertures will allow a certain acquisition, i.e., liquid can be transported to the absorbent structure of the product.	05-05-2011

Elisabeth Borredon, Tournefeuille FR

Patent application number	Description	Published
20100291398	METHOD FOR TREATING LIGNOCELLULOSIC MATERIALS, IN PARTICULAR WOOD AND MATERIAL OBTAINED BY SAID METHOD - Process for the chemical treatment of lignocellulose materials, in particular of at least one piece of wood, characterized in that said materials are subjected to impregnation by a chemical agent comprising hydrocarbonaceous chains, this agent being chosen from mixed anhydrides, except for the mixed anhydride of acetic/benzoic acid, said agent being suitable for providing covalent grafting of a plurality of hydrocarbonaceous chains to said materials.	11-18-2010

Elisabeth Buchdunger, Neuenburg DE

Patent application number	Description	Published
20090202541	COMBINATION COMPRISING N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2-METHYLPHENYL)-4-(3-P- YRIDYL)-2PYRIMIDINE-AMINE AND A CHEMOTHERAPEUTIC AGENT - A method of treating a warm-blooded animal, especially a human, having a proliferative disease or acute or chronic transplant rejection comprising administering to the animal a combination which comprises (a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and (b) a chemotherapeutic agent selected from antineoplastic agents, especially as defined herein, and agents effective in treating acute or chronic transplant rejection; a combination comprising (a) and (b) as defined above and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease, especially a solid tumor disease.	08-13-2009
20100179179	INHIBITORS OF THE MUTANT FORM OF KIT - The present invention relates to the treatment of KIT dependent diseases that are characterized by a mutant form of KIT whereby the mutant KIT is identified and an appropriate inhibitor of the mutant KIT is administered.	07-15-2010
20110124670	Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis - The invention relates to the use of a pyrimidylaminobenzamides of formula I	05-26-2011

Elisabeth Bukaman, Magstadt DE

Patent application number	Description	Published
20090115589	Method and Computer Program for Identification of Inattentiveness by the Driver of a Vehicle - A method and a computer program for identifying when the driver of a vehicle, in particular a motor vehicle, is not paying attention. In order to make it possible to make a more reliable statement on the presence of any inattentiveness by the driver, the method observes a steering action following a steering quiescent phase, in addition to detecting the steering quiescent phase. The extent of the steering quiescent phase and of the steering action found are logically linked to one another, and the result of this logical operation is then used as a measure for the severity of the inattentiveness of the driver.	05-07-2009

Elisabeth Chuiton, Revel FR

Patent application number	Description	Published
20080231556	ACTIVE MATRIX OF AN ORGANIC LIGHT-EMITTING DIODE DISPLAY SCREEN - In an active matrix for an organic light-emitting diode display screen, each pixel is arranged between two row select lines, each line controlling at least a first switching transistor T	09-25-2008
20090096725	ORGANIC ELECTROLUMINESCENT DISPLAY - In an organic light-emitting display screen, each picture dot includes an organic diode (OLED) and first and second current driver circuits for the diode. Each driver circuit includes: a driving transistor connected between a reference voltage and one electrode of the said diode, a switching transistor for switching a gate voltage onto the gate of the said driving transistor, and a capacitor connected to the gate of the said driving transistor, to maintain the gate voltage. The gate voltage of a driving transistor is alternately a video voltage controlling a display phase, or a turn-off voltage, controlling a recovery phase. The driving transistors are controlled alternately, one in recovery phase, the other in display phase, and vice versa.	04-16-2009

Elisabeth Clamer, Darmstadt DE

Patent application number	Description	Published
20090176928	SUBDUEDLY COLORED, INFRARED REFLECTING PLASTIC COMPOUND - The invention relates to subduedly colored (brown, gray, black, green), infrared reflecting PMMA compounds which can be applied to other plastic compounds as an IR barrier layer	07-09-2009

Elisabeth Couve, Rambouillet FR

Patent application number	Description	Published
20090162847	RAPID DETECTION OF THE "HIGH-VIRULENT" ST-17 CLONE OF GROUP B STREPTOCOCCUS - The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B	06-25-2009

Elisabeth Crochon, Poisat FR

Patent application number	Description	Published
20080214108	Contactless Communications Method Based On Asynchronous Modulations And Demodulations - The invention relates to a method for exchanging information by inductive coupling or without contact between a reader (	09-04-2008
20110148588	DEVICE FOR THE SECURE CONTACTLESS DATA EXCHANGE BETWEEN A READER AND A CARD - The invention relates to a contactless data exchange system provided with a transponder comprising:	06-23-2011

Elisabeth Cura, Duesseldorf DE

Patent application number	Description	Published
20100142226	LIGHT GUIDE FOR A LIGHTING DEVICE - A lighting device comprises a side-light light guide (	06-10-2010

Elisabeth Cura, Darmstadt DE

Patent application number	Description	Published
20080308222	NANOPARTICULATE PREPARATION - The invention relates to nanoparticulate preparations containing at least one mixed metal oxide in the form of supramagnetic, nanoscale particles, methods for heating such a preparation, and methods for producing and dissolving adhesive compounds on the basis of said preparations.	12-18-2008
20090133822	NANOPARTICULATE PREPARATION - The invention relates to nanoparticulate preparations containing at least one mixed metal oxide in the form of supramagnetic, nanoscale particles, methods for heating such a preparation, and methods for producing and dissolving adhesive compounds on the basis of said preparations.	05-28-2009

Elisabeth Dam, Paris FR

Patent application number	Description	Published
20080280849	Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents - The invention relates to a combination comprising a quinoline compound or its sail, according to general formula (I) and at least one HIV infection therapeutic agent selected from the group consisting of entry inhibitors, reverse-transcriptase inhibitors, strand-transfer inhibitors, protease inhibitors, and maturation inhibitors. Said combination has therapeutic synergy in the treatment of an HIV infection compared with the quinoline compound, or HIV infection therapeutic agent alone.	11-13-2008

Elisabeth Davioud-Charvet, Perenchies FR

Patent application number	Description	Published
20110059972	1,4-NAPHTHOQUINONES DERIVATIVES AND THERAPEUTIC USE THEREOF - 1,4 naphthoquinones derivatives, of formula (I)	03-10-2011

Elisabeth Delcourt Debruyne, Lambersart FR

Patent application number	Description	Published
20080254094	Biomaterials Carrying Cyclodextrines Having Improved Absorption Properties and Used for the Progressive and Delayed Release of Therapeutic Molecules - The present invention relates to a method of preparation of a biomaterial containing at least one bioactive molecule from a base biomaterial, characterized by the following successive operations carried out on the aforesaid base biomaterial:	10-16-2008

Elisabeth Delevoye, Grenoble FR

Patent application number	Description	Published
20080213539	Thin Film Getter Protection - The invention relates to a method of maintaining the optimal properties of a thin film getter (	09-04-2008
20090249873	OSCILLATING MASS RESONATOR - Suspension and coupling beams of oscillating masses in a device which serves, for example, as a gyro and that includes oscillating masses form a single continuous network that allows the device to have a compact design. Preferably, a junction beam surrounds the two masses.	10-08-2009

Elisabeth Djurado, Crolles FR

Patent application number	Description	Published
20110110864	FLUORESCENT NANOCRYSTALS ENCAPSULATED IN AN INORGANIC SHELL - The present invention relates to a method of preparing hybrid organo/mineral nanoparticles comprising an organic fluorescent crystalline core encapsulated in an inorganic shell, and to nanoparticles that can be obtained by said method. The method of the present invention comprises the following steps: (i) a sol-gel mixture able to be obtained by a process comprising the addition, in at least one organic solvent, in the presence of water, of a fluorescent organic compound and at least one metal alkoxide is sprayed; (ii) the sprayed sol-gel mixture is dried, by evaporating the solvent and the water that are present in the sol-gel mixture. The nanoparticles of the present invention can be used for example as a tracer in medical imaging or as a chemical sensor.	05-12-2011

Elisabeth Dolff, Falun SE

Patent application number	Description	Published
20090107645	Process for the Production of a Paper and a Paper Produced According to the Process - A process for producing paper from a furnish comprising fillers and fibers, wherein the furnish is treated with polymers in at least three steps and said furnish contains fillers in such an amount that the paper product obtained by the process contains at least 15% by weight of fillers. The invention also relates to a paper product produced according to the process of the present invention.	04-30-2009

Elisabeth Dufour-Gergam, Fontenay Aux Roses FR

Patent application number	Description	Published
20110165365	METHOD AND DEVICE FOR ENCAPSULATING MICROSTRUCTURES - A method for encapsulating structures (	07-07-2011

Elisabeth Dupont-Passelaigue, Castres FR

Patent application number	Description	Published
20110118266	DERIVATIVES OF TRIAZINES AND URACILS, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPEUTICS - The present invention relates to derivatives of general formula I wherein: —W represents nitrogen, —R	05-19-2011

Elisabeth Erhardtsen, Hellerup DK

Patent application number	Description	Published
20090018082	Use of Factor VIIa or Factor VIIa Equivalents for Treating Trauma - The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for treatment of trauma.	01-15-2009
20100062983	Use of Factor VIIa or Factor VIIa equivalents for treating late complications of trauma - The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for preventing late complications in trauma patients.	03-11-2010

Elisabeth Evertsz, San Jose, CA US

Patent application number	Description	Published
20090023671	Rnai Agents for Maintenance of Stem Cells - The present invention provides compositions and methods suitable for delivering RNAi agents against genetic targets in stem cells so as to direct cell growth and differentiation.	01-22-2009
20090209628	MULTIPLE RNAi EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS RELATED TO HETEROZYGOTIC EXPRESSION PATTERNS - The present invention provides compositions and methods suitable for expressing y-x multiple-RNAi agents against an allele or alleles of interest in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases.	08-20-2009

Elisabeth Fontan, Boulogne FR

Patent application number	Description	Published
20110159598	CRYSTAL STRUCTURE OF THE CCZ-LZ DOMAIN OF NEMO - The invention relates to a crystal of the CC2-LZ domain of the NEMO protein, in which the three-dimensional structure has been determined by X-ray diffraction at a resolution of about 3.25 A. The invention also relates to methods for the crystallisation of the CC2-LZ domain. The CC2-LZ crystals and the information derived from the crystalline structures thereof are used for identifying and designing compounds interacting with CC2-LZ.	06-30-2011

Elisabeth Garanger, Bordeaux FR

Patent application number	Description	Published
20110159566	Methods and Reagents for Preparing Multifunctional Probes - Multifunctional probes are synthesized in a single step using peptide scaffold-based multifunctional single-attachment-point reagents. To obtain multifunctional probes using the methods of the invention, a substrate (e.g., a nanoparticle, polymer, antibody, protein, low molecular weight compound, drug, etc.) is reacted with a multifunctional single-attachment-point (MSAP) reagent. The MSAP reagents can include three components: (i) a peptide scaffold, (ii) a single chemically reactive group on the peptide scaffold for reaction of the MSAP with a substrate having a complementary reactive group, and (iii) multiple functional groups on the peptide scaffold. The peptide scaffold can include any number of residues; however, for ease of synthesis and reproducibility in clinical trials, it is preferred to limit the residues in the peptide to 20 or less. The reagent can be prepared to yield a predetermined stoichiometric ratio of the functional groups on the scaffold such that the probe has a fixed stoichiometric ratio of the functional groups.	06-30-2011

Elisabeth Gingelmeier, Utting DE

Patent application number	Description	Published
20090154143	HEAD BAND FOR DIAGNOSTIC INSTRUMENTS COMPRISING LIGHT SOURCE AND BATTERY - A head band for diagnostic instruments comprising a light source and a battery has, at its back support part (	06-18-2009

Elisabeth Hebesberger, Linz AT

Patent application number	Description	Published
20110160373	PROCESS FOR THE PRODUCTION OF POLYOLEFINS WITH BROAD MOLECULAR WEIGHT DISTRIBUTION - The present invention is directed to a propylene homo- or copolymer having a polydispersity index (P	06-30-2011

Elisabeth Hendriksson, Kode SE

Patent application number	Description	Published
20090206010	REVERSE FROTH FLOTATION OF CALCITE ORE - The invention relates to a reverse froth flotation process for treating a calcium carbonate ore containing silicates. The process comprises the use of two collectors selected from the group consisting of fatty tri-lower-alkyl quaternary ammonium compounds, fatty di-lower-alkyl benzyl quaternary ammonium compounds, fatty lower-alkyl di-benzyl quaternary ammonium compounds, di-fatty di-lower-alkyl quats, di-fatty lower-alkyl benzyl quats, and fatty bis-imidazoline quats. The use of a combination of different quats was found to result in a synergetic performance of the collectors.	08-20-2009

Elisabeth Hildebrandt-Eriksen, Skibby DK

Patent application number	Description	Published
20090298916	Pharmaceutical compositions for treatment of microRNA related diseases - The present invention provides compositions and methods of treatment of diseases that are sensitive to drugs that downregulate the function of microRNA's, mRNA, non-coding RNA, or viral genomes. In particular, it has been discovered that a very long term effect of an anti microRNA oligonucleotide may be obtained when administered to a primate. Therefore, the present invention relate to pharmaceutical compositions and methods for treatment of primates, including humans wherein the compositions are administered with a long time interval.	12-03-2009
20110077288	Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases - The present invention provides compositions and methods of treatment of diseases that are sensitive to drugs that downregulate the function of microRNA's, mRNA, non-coding RNA, or viral genomes. In particular, it has been discovered that a very long term effect of an anti microRNA oligonucleotide may be obtained when administered to a primate. Therefore, the present invention relate to pharmaceutical compositions and methods for treatment of primates, including humans wherein the compositions are administered with a long time interval.	03-31-2011

Elisabeth Hustert, Germering DE

Patent application number	Description	Published
20090297580	SPINAL NUCLEUS PULPOSUS IMPLANT - The present invention relates to a spinal nucleus pulposus implant for use in the treatment of the intervertebral disc and in particular, to the use of a CD-RAP protein therefore.	12-03-2009
20110002972	NEUROENDOCRINE FACTORS FOR TREATMENT OF DEGENERATIVE DISEASES - The present invention is related to the use of a repellent factor and/or polypeptide for manufacturing of a pharmaceutical composition for treating a disease such as a degenerative disease in particular to the use of a SLIT3 or NETRIN1 protein therefore. The invention is further related to a polypeptide fragment of SLIT3, a pharmaceutical composition comprising the polypeptide and the use thereof.	01-06-2011

Elisabeth Hutson, Upper Poppleton GB

Patent application number	Description	Published
20080243029	TISSUE HARVESTING - The present disclosure relates to a tissue collection apparatus including a housing defining an inlet and an outlet and a tissue scaffold suitable for disposal within the housing, the tissue scaffold configured to be loaded with the tissue under the application of an aspiration force applied through the tissue collection apparatus.	10-02-2008

Elisabeth Kaifer, Heidelberg DE

Patent application number	Description	Published
20100172825	Molecular Hydrogen Stores and Hydrogen Transfer Reagents for Hydrogenation Reactions - The present invention relates to a process for reversible hydrogen storage, to a material for reversible hydrogen storage and to the use of the material for reversible hydrogen storage.	07-08-2010

Elisabeth Kommisrud, Stange NO

Patent application number	Description	Published
20100041941	Preservation and Controlled Delivery / Release of Spermatozoa - The present invention relates to biopolymer particles for preservation of spermatozoa, wherein the spermatozoa are embedded within the biopolymer particle. The present invention also regards a method for preservation, storage and controlled delivery/release of spermatozoa, and the use of the biopolymer particles according to the present invention in breeding.	02-18-2010

Elisabeth Laugier-Laglenne, Paris FR

Patent application number	Description	Published
20100221684	IMPLANT FOR SUBCUTANEOUS OR INTRADERMAL INJECTION - The invention concerns an injection implant for filling up wrinkles, thin lines, skin cracks and scars, for reparative or plastic surgery, aesthetic dermatology, and for filling up gums in dental treatment. The invention concerns the use of biologically absorbable polymer microspheres or microparticles suspended in a gel. Said suspension is produced either ready-for-use or freeze-dried. The biological absorbability of the microspheres is controlled and enables the production of implants having well defined persistence and deliberately limited to 3 years.	09-02-2010

Elisabeth Le Nestour, Paris FR

Patent application number	Description	Published
20080220068	TREATMENT AND PREVENTION OF EXCESSIVE SCARRING - A pharmaceutical composition comprised of a hydration agent and an anesthetic can be used to treat excessive scarring conditions, such as keloid and hypertrophic scars.	09-11-2008
20090203796	TREATMENT AND PREVENTION OF BENIGN BREAST DISEASE WITH 4-HYDROXY TAMOXIFEN - The present invention provides methods for treating and preventing benign breast disease by administering 4-hydroxy tamoxifen to a patient. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with benign breast disease, this effect induces disease regression. In patients at risk for developing breast cancer, the anti-estrogenic effect prevents formation of benign breast conditions that can lead to cancer.	08-13-2009

Elisabeth Lepoil, Chantepie FR

Patent application number	Description	Published
20100171881	GENERATION OF A CUSTOMIZABLE TV MOSAIC - Method for generating at least one mosaic of content-transport streams, said method comprises the following steps after displaying a screen including at least a first area (Z	07-08-2010

Elisabeth Liljensten, Kungsbacka SE

Elisabeth Masset-Bosc, Plaisance Du Touch FR

Patent application number	Description	Published
20090166474	Baggage Accommodation Device - A baggage accommodation device for an aircraft, which device comprises a plurality of first rollers and a container, wherein the container comprises a base plate. The plurality of first rollers are arranged on the base plate, and the baggage accommodation device is designed such that it is sufficiently stable for said baggage accommodation device to be able to be moved into and out of the aircraft.	07-02-2009

Elisabeth Mayrhuber, Kapfenberg AT

Patent application number	Description	Published
20100304457	Method for producing biogas in controlled concentrations of trace elements - A method for producing biogas from biomass in a biogas reactor, wherein	12-02-2010

Elisabeth Meyer, Miesbach DE

Patent application number	Description	Published
20100189793	ELECTROPHORETIC TRANSDERMAL DELIVERY SYSTEM - A transdermal delivery system (TDS) for administering at least one active agent through the skin. The system has a first electrode, a second electrode, and a matrix located between the first and second electrodes. The TDS contains at least one active agent which is either alkaline or acidic. The system is configured such that when applying a voltage to the electrodes, the pH of the matrix, in the case of an alkaline active agent, does not exceed the pH of the active agent and, in case of an acidic active agent, does not fall below the pH of the active agent.	07-29-2010

Elisabeth Meyer, Langenselbold DE

Patent application number	Description	Published
20100243956	LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY - The present invention relates to dielectrically positive liquid-crystalline media comprising a dielectrically positive component, component A, comprising a dielectrically positive compound of the formula (I), in which the parameters have the meaning indicated in the specification, and optionally a second dielectrically positive component, component B, comprising one or more dielectrically positive compounds having a dielectric anisotropy of greater than 3 and optionally a dielectrically neutral component, component C, and to liquid-crystal displays, especially to active-matrix displays and in particular to TN, IPS, FFS and OCB displays, containing these media.	09-30-2010
20100314582	LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY - The present invention relates to dielectrically positive liquid-crystalline media comprising one or more compounds of the formula I	12-16-2010

Elisabeth Meyer, Hanau DE

Patent application number	Description	Published
20100134751	LIQUID-CRYSTALLINE MEDIUM - The invention relates to a liquid-crystalline medium having negative dielectric anisotropy based on a mixture of polar compounds, which comprises at least one compound of the formula I	06-03-2010

Elisabeth Miot-Noirault, Clermont-Ferrand FR

Patent application number	Description	Published
20110044899	LABELLED ANALOGUES OF HALOBENZAMIDES AS MULTIMODAL RADIOPHARMACEUTICALS AND THEIR PRECURSORS - A compound of formula (I): in which R	02-24-2011

Elisabeth Naschberger, Erlangen DE

Patent application number	Description	Published
20100048415	METHOD FOR THE DETECTION OF INTERFERON-ASSOCIATED ANGIOSTATIC TUMORSTAGES IN COLORECTAL CARCINOMA - The present invention is directed to a microarray for the detection of an angiostatic tumor stage/tumor area of colorectal carcinoma in a patient, wherein the microarray comprises gene probes capable of specifically hybridizing to predefined nucleic acids. The invention is further directed to an inhibitor or modulator of one or more of these nucleic acids, as well as to a pharmaceutical composition, comprising those inhibitors or modulators. In a further aspect, the present invention is directed to an ex vivo method for the diagnosis of an angiostatic tumor stage/tumor area in a patient suffering from a colorectal carcinoma. In a further aspect the invention is directed to predict the response of patients with colorectal carcinoma but also other diseases to therapy.	02-25-2010

Elisabeth Penunuri, Tempe, AZ US

Patent application number	Description	Published
20080299870	Adjustable strap for brassiere having shoulder and body engaging means - The brassiere includes a left and a right cup, each having a proximate side, a distal side, and a top side. The proximate sides of the cups are attached. A left shoulder blade portion is attached to the distal side of the left cup. A right shoulder blade portion is attached to the distal side of the right cup. A first sleeve is formed in the left shoulder blade portion. A second sleeve is formed in the right shoulder blade portion. A first shoulder strap is connected to the right shoulder blade portion and traverses the first sleeve. A second shoulder strap is connected to the left shoulder blade portion and traverses the second sleeve. The shoulder straps are also connected to the top side of the left cup and the top side of the right cup.	12-04-2008

Elisabeth Perez Cabre, Terrassa ES

Patent application number	Description	Published
20090201464	Optical Device, Ophthalmic Lens and Device for Correcting Long-Sightedness - Optical device that comprises a spatial light modulator and a spectral filter that normally comprise several parts, such that each part of the filter (V; R; A; L) corresponds to at least one part of the modulator. The spectral filter is superimposed to the spatial light modulator such that the transmittance of each part of the filter is coordinated with the phase offset introduced by the corresponding part of the modulator. In one embodiment, the spatial light modulator is a programmable liquid-crystal device. The invention presents several ways in which to coordinate the transmittance of each part of the spectral filter with the programmed time variation of the phase offset introduced by each part of the spatial light modulator, such that each part of the latter receives light at a spectrally filtered wavelength and focuses it in the same plane.	08-13-2009

Elisabeth Pfuetzner-Riehn, Mainz DE

Patent application number	Description	Published
20110014613	Genotyping for Risk of Atherosclerosis - The invention provides a kits, compositions and methods useful for determining atherosclerotic risk in a subject. In one aspect, the invention provides kit comprising a solid support comprising a capture probe set comprising a plurality of probes selected from (a) a probe selective for PTGS1, (b) a probe selective for PTGS2, (c) a probe selective for NOS3, (d) a probe selective for SERPINE1, (e) a probe selective for F5, (f) a probe selective for MTHFR, (g) a probe selective for ALOX5AP, (h) a probe selective for CETP, (i) a probe selective for APOE, (j) a probe selective for F2, (k) a probe selective for ACE, (l) a probe selective for LTA and (m) a probe selective for LPL.	01-20-2011

Elisabeth Picard-Lesboueyries, Velizy FR

Patent application number	Description	Published
20100267606	FRAGRANCING COMPOSITION COMPRISING AN AMPHIPHILIC COPOLYMER OF 2 ACRYLAMIDOMETHYLPROPANE-SULPHONIC ACID AND OPTIONALLY A CELLULOSE ALKYL ETHER AND/OR AN ALKYLCELLULOSE ALKYL ETHER - The invention relates to a fragrancing composition comprising, in a cosmetically acceptable medium: a) at least 1% by weight relative to the total weight of the composition of at least one fragrancing substance; b) at least one volatile alcohol and/or one volatile silicone oil; c) at least one crosslinked or uncrosslinked amphiphilic copolymer of partially or completely neutralized 2-acrylamidomethylpropanesulphonic acid (AMPS) monomer (A) and at least one hydrophobic monomer (B) d) optionally at least a cellulose alkyl ether and/or an alkylcellulose alkyl ether, the alkyl radicals being linear or branched saturated C	10-21-2010

Elisabeth Pistotnik, Creteil FR

Patent application number	Description	Published
20080280329	Enzymatic synthesis of deoxyribonucleosides - The present invention relates to a method for the in vitro synthesis of deoxyribonucleosides and enzymes suitable for this method.	11-13-2008

Elisabeth Pook, Wuppertal DE

Patent application number	Description	Published
20090312381	Substituted Arylimidazolone and Triazolone as Inhibitors of Vasopressin Receptors - The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.	12-17-2009
20100261771	SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF - The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.	10-14-2010

Elisabeth Prezborn, Wuppertal DE

Patent application number	Description	Published
20100010060	Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof - The invention relates to novel isoindolin-1-one, isoindolin-3-one and isoindoline-1,3-dione derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolic disorders.	01-14-2010

Elisabeth Richeux, La Ciotat FR

Patent application number	Description	Published
20080280513	Amphibious Vehicle Which Has Elements for Forming a Floating Bridge - An amphibious vehicle which has elements, such as caissons, floats, and ramps, arranged on a self-propelled rolling base, oriented essentially parallel to a longitudinal axis of the rolling base, when the vehicle is in a folded configuration for movement on land, and which are deployed to form a track or bridge portion oriented transversely with respect to the longitudinal axis of the rolling base, when the vehicle, alone or with another vehicle of the same design, is used to form a floating bridge or ferry. The vehicle has a deployment device for deploying elements by pivoting of four groups of the elements around four vertical shafts spaced from one another, according to at least three different configurations, each group of elements including at least one caisson.	11-13-2008
20090038527	Dispositif de modification de la carene d'un corps flottant et vehicule amphibie comportant un tel dispositif - A device for modifying a hull of a floating body of a floating vehicle or floating bridge, having a base floating body, with an upper surface forming a principal rolling path, and first and second lateral surfaces. On each side of the base floating body, a first movable wall which is mounted so that it pivots on a lower part of the corresponding lateral surface of the base floating body, a second movable wall is mounted so that it pivots on the first movable wall, and a third movable wall is mounted so that it pivots about the second movable wall The three movable walls are arranged with respect to each other so that, in a folded position, the first movable wall is essentially parallel to the first lateral surface of the base floating body, and the second and third movable walls partially cover the upper surface of the base floating body. In a deployed position, the first movable wall delimits a volume between itself and the first lateral surface, the second movable wall extends the first movable wall, and the third movable wall forms an additional path broadening the upper surface.	02-12-2009
20090106917	SYSTEM FOR TRANSPORTING A SPAN ON A ROAD VEHICLE CAPABLE OF BEING TRANSFORMED INTO AN AMPHIBIOUS VEHICLE ENABLING THE CROSSING OF A DRY OR WATER-FILLED GAP BY ANY ROAD VEHICLE - A system for transporting a span on a road vehicle capable of being transformed into an amphibious vehicle enabling crossing of a dry or water-filled gap by any road vehicle. The vehicle for transporting the span is amphibious to allow any vehicle to cross a gap filled with water by transferring and transporting the vehicle on the span supported on the amphibious vehicle operating as a floating ferry. The invention is particularly applicable in the field of civil or military engineering.	04-30-2009
20100112876	AMPHIBIOUS VEHICLE FOR BREACHING A WATER-FILLED OPENING - An amphibious vehicle includes caissons, floats, and ramps stored on top of one another on a self-propelled rolling base, when the vehicle is in a folded configuration for driving over firm ground. The elements can be deployed transversely with respect to a longitudinal axis of the rolling base when the vehicle, alone or with another vehicle of the same design, forms a pontoon or a ferry to breach a water-filled opening. The vehicle includes a deployment device to deploy the elements on one side before beginning to deploy the elements on the other side of the rolling base. The elements are deployed in at least three different configurations. The elements on each side, include respectively, from the inside outwards, in the deployed configuration, a caisson, a float, and a ramp which are hinged together in a Z-configuration.	05-06-2010

Elisabeth Rothl, Vienna AT

Patent application number	Description	Published
20100003221	Medium Supplement for Virus Production - The use of macrolide polyene antibiotics or derivatives or analogues thereof as culture supplement for the propagation of virus is described. Further pharmaceutical compositions comprising a virus and a macrolide polyene antibiotic or a derivative or analogue thereof and methods for using of macrolide polyene antibiotics for transfection and infection of cells as well as the use of macrolide poylene antibiotics for the isolation of virus from clinical samples are disclosed.	01-07-2010
20100158944	Method for influenza virus protection - A process for the purification of influenza virus or derivative thereof comprising the steps of:	06-24-2010

Elisabeth Röthl, Vienna AT

Patent application number	Description	Published
20100003221	Medium Supplement for Virus Production - The use of macrolide polyene antibiotics or derivatives or analogues thereof as culture supplement for the propagation of virus is described. Further pharmaceutical compositions comprising a virus and a macrolide polyene antibiotic or a derivative or analogue thereof and methods for using of macrolide polyene antibiotics for transfection and infection of cells as well as the use of macrolide poylene antibiotics for the isolation of virus from clinical samples are disclosed.	01-07-2010

Elisabeth Schärtl, Dachau DE

Patent application number	Description	Published
20100024190	CONNECTION PROCESS AND FRAMING DEVICE - A framing device (	02-04-2010

Elisabeth Schärtl, Dachau DE

Patent application number	Description	Published
20100024190	CONNECTION PROCESS AND FRAMING DEVICE - A framing device (	02-04-2010

Elisabeth Scholvinck, Groningen NL

Patent application number	Description	Published
20090317854	Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase - Diagnostic testing and immunomonitoring that uses genetically detoxified	12-24-2009

Elisabeth Smela, Silver Spring, MD US

Patent application number	Description	Published
20080277631	Electrically Conductive Metal Impregnated Elastomer Materials and Methods of Forming Electrically Conductive Metal Impregnated Elastomer Materials - An electrically conductive, compliant elastomer material that is impregnated with a metal is formed by combining a metal salt with an elastomer precursor material to form a metal salt/precursor mixture, curing the metal salt/precursor mixture to form an elastomer impregnated with metal salt, and treating the elastomer impregnated with metal salt with a chemical reducing composition so as to convert at least a portion of the metal salt impregnated within the elastomer to a metal. The elastomer can be subjected to a suitable solvent that swells the elastomer during the chemical reduction of the metal salt to metal, which enhances the mechanical and electrical properties of the resultant metal impregnated elastomer material.	11-13-2008

Elisabeth Smith, Kulpsville, PA US

Patent application number	Description	Published
20090173546	EARTH BIT WITH HUB AND THRUST UNITS - An earth bit includes a cone rotatably mounted to a shaft with a hub unit and thrust roller bearings. The hub unit is moveable between mounted and unmounted positions on the shaft, as a single unit, in a repeatable manner. The hub unit includes a pair of roller bearings positioned between inner and outer races. The outer race includes a recess extending around its outer periphery. A sealing structure is slidingly engaged with the recess to provide a seal between the cone and shaft.	07-09-2009

Elisabeth Sommer, Alzenau DE

Patent application number	Description	Published
20100098852	ARRANGEMENT AND METHOD FOR REGULATING A GAS STREAM OR THE LIKE - An arrangement for the regulation of a gas stream or the like is provided, which comprises at least one vaporizer crucible for the vaporization of a material or at least one supply container with material vapor. The vaporized material or the material vapor is conducted via a vapor conduit to a substrate. The at least one vaporizer crucible or the at least one supply container is connected via a dosing pipe with the vapor conduit. A tappet projects into the dosing pipe. By means of a regulator the position of the tappet in the dosing pipe is regulated as a function of a measured variable.	04-22-2010
20100098853	ARRANGEMENT FOR VAPORIZING MATERIALS AND METHOD FOR COATING SUBSTRATES - The invention relates to an arrangement for the vaporization of materials, and specifically of organic materials, such as are utilized for example in the production of OLEDs. A heating element and a device for transporting a carrier for a layer to be vaporized are herein provided. The carrier with the layer to be vaporized is guided over the heating element where the layer is vaporized and deposited on a substrate.	04-22-2010
20100154905	ARRANGEMENT FOR THE REGULATION OF A GAS STREAM - The invention relates to an arrangement for the regulation of a gas stream, with a dosing pipe (	06-24-2010
20100159123	EVAPORATION SOURCE WITH EXCHANGEABLE NOZZLES - The invention refers to an evaporation source for depositing of thin layers on substrates, the evaporation source comprising a vapor distribution system having an evaporation pipe made of inorganic non metallic material, with the evaporation pipe having at least one nozzle, wherein the nozzle is disposed in a nozzle element which is made as a separate component being arranged in a nozzle element opening of the evaporation pipe.	06-24-2010
20100159125	METHOD AND APPARATUS FOR DEPOSITING MIXED LAYERS - The present invention refers to a method as well as an apparatus for depositing a layer at a substrate, the layer containing at least two components co-deposited by at least two evaporation sources, wherein the mixture of the components regarding the content of the components is set by tilting the evaporation sources to predetermined angle and/or by positioning the evaporation sources at a predetermined distance with respect to the substrate and/or wherein evaporation plumes of the evaporation sources are arranged such that the maxima of the evaporation plumes are separated locally with respect to the substrate.	06-24-2010
20100316788	DEPOSITION RATE MONITOR DEVICE, EVAPORATOR, COATING INSTALLATION, METHOD FOR APPLYING VAPOR TO A SUBSTRATE AND METHOD OF OPERATING A DEPOSITION RATE MONITOR DEVICE - A deposition rate monitor device for monitoring the deposition rate of a vapor on a substrate is provided, including: a piezoelectric crystal monitor device including a piezoelectric crystal monitor provided in a housing, wherein the housing includes a vapor inlet aperture, and at least one elongated shielding device having a first end and a second end, the first end encompassing the vapor inlet aperture.	12-16-2010

Elisabeth Souhami, Les Pavillons Sous Bois FR

Patent application number	Description	Published
20110118178	METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO INSULIN GLARGINE AND METFORMIN - A method for the treatment of diabetes mellitus type 2 comprising administering	05-19-2011

Elisabeth Sthengel, Helsingborg SE

Patent application number	Description	Published
20100260688	New Formulation and Use Thereof - Provided are liquid pharmaceutical formulations comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a t	10-14-2010

Elisabeth Strandemo, Karlskrona SE

Patent application number	Description	Published
20100078195	HIGH VOLTAGE CABLE - An extruded high voltage cable including a conductor with at least three concentric layers of helically wound metal wires, an extruded inner conducting layer surrounding the conductor, and an extruded electrical insulation arranged outside the inner conducting layer. The two outermost layers of the conductor have the same lay direction.	04-01-2010

Elisabeth Thomassen-Wolf, Martinsried DE

Patent application number	Description	Published
20090202547	ANTIBODIES THAT BLOCK RECEPTOR PROTEIN TYROSINE KINASE ACTIVATION, METHODS OF SCREENING FOR AND USES THEREOF - Molecules comprising the antigen-binding portion of antibodies that block constitutive and/or ligand-dependent activation of a receptor protein tyrosine kinase, such as fibroblast growth factor receptor 3 (FGFR3), are found through screening methods, where a soluble dimeric form of a receptor protein tyrosine kinase is used as target for screening a library of antibody fragments displayed on the surface of bacteriophage. The molecules of the present invention which block constitutive activation can be administered to treat or inhibit skeletal dysplasia, craniosynostosis disorders, cell proliferative diseases or disorders, or tumor progression associated with the constitutive activation of a receptor protein tyrosine kinase.	08-13-2009

Elisabeth Thomassen-Wolf, Gauting DE

Patent application number	Description	Published
20090053213	Anti-Gm-Csf Antibodies and Uses Therefor - The present invention provides recombinant antigen-binding regions, antibodies and functional fragments thereof that are specific for GM-CSF, which plays an integral role in various disorders or conditions. These antibodies, accordingly, can be used to treat, for example, inflammatory diseases such as rheumatoid arthritis. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of GM-CSF in the progression of various disorders. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use.	02-26-2009
20110045000	Anti-GM-CSF antibodies and uses therefor - The present invention provides recombinant antigen-binding regions, antibodies and functional fragments thereof that are specific for GM-CSF, which plays an integral role in various disorders or conditions. These antibodies, accordingly, can be used to treat, for example, inflammatory diseases such as rheumatoid arthritis. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of GM-CSF in the progression of various disorders. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use.	02-24-2011

Elisabeth Townsdin, Seattle, WA US

Patent application number	Description	Published
20080304630	Automatic emergency call notification to pre-designated personal emergency contacts - Automatic notification is provided to pre-designated emergency contacts for a given wireless subscriber upon the occurrence of an emergency call from the subscriber. Triggering for the automatic notification may take place at an appropriate time in the emergency call, e.g., at a time the emergency call is received, at a time during the emergency call after a current location of the emergency caller is obtained by the emergency network, once the emergency call terminates, after a set amount of time after the emergency call is received, terminates, etc. The automatic notification is preferably made using voice over Internet Protocol (VoIP), but may instead be pre-designated by the subscriber to be in an alternative mode, e.g., by SMS, switched telephone, etc. An option is included for the emergency caller to cancel the automatic notification. The location of the emergency caller may be configurably provided to a notified emergency contact.	12-11-2008

Elisabeth Weiss, Muenchen DE

Patent application number	Description	Published
20100203086	ATTACK OF TUMOR CELLS WITH MISSING, LOW OR ABERRANT MHC EXPRESSION BY COMBINING NON MHC-RESTRICTED T-CELLS/NK-CELLS AND MHC-RESTRICTED CELLS - This invention is directed to therapeutic compositions containing non-MHC-restricted Tcells/NK-cells in combination with MHC-restricted T-cells and especially to therapeutic compositions, which comprise LAK cells. Furthermore, the present invention is directed to the use of the above combination in the treatment of tumors in humans, which tumors show a missing, low or aberrant expression of MHC class Ia or Ib molecules. By using the aforementioned compositions/combinations it is possible to provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection.	08-12-2010

Elisabeth Wolf-Heuss, Mosbach DE

Patent application number	Description	Published
20090142407	Solid peptide preparations for inhalation and their preparation - The invention relates to solid pharmaceutical preparations, in particular for inhalatory administration in mammals, their preparation and their use such as, for example, in powder inhalers.	06-04-2009